Pooled safety analysis of pimitespib for the treatment of patients with advanced gastrointestinal stromal tumors
This analysis suggests that most ADRs associated with pimitespib are manageable and reversible, thus supporting its use in patients with advanced GIST.
Authors
- Toshihiko Doi (ORCID: https://orcid.org/0000-0003-2042-6829)
- Noboru Yamamoto (ORCID: https://orcid.org/0000-0002-0787-2851)
- Yukinori Kurokawa (ORCID: https://orcid.org/0000-0002-2883-0132)
- Yuko Hirano
- Chenyao Sun (ORCID: https://orcid.org/0000-0002-2035-3888)
- N. Arimura
Institutions
- Osaka City University (JP)
- Taiho Pharmaceutical (Japan) (JP)
- National Cancer Center Hospital East (JP)
- Tokyo National Hospital (JP)
- The University of Osaka (JP)
Publication Details
- Journal
- International Journal of Clinical Oncology
- Published
- 2025-11-20
- DOI
- https://doi.org/10.1007/s10147-025-02917-9
- Primary Topic
- Gastrointestinal Tumor Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Taiho Pharmaceutical